BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6647215)

  • 1. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative haemodynamic dose-response effects of dobutamine and amrinone in left ventricular failure complicating acute myocardial infarction.
    Silke B; Verma SP; Midtbo KA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):19-25. PubMed ID: 2434789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic dose-response effects of a transdermal nitrate delivery system in acute myocardial infarction with and without left heart failure.
    Verma SP; Silke B; Reynolds GW; Hafizullah M; Nelson GI; Jackson NC; Taylor SH
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):151-7. PubMed ID: 2452308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Walker C; Taylor SH
    Int J Cardiol; 1984 Mar; 5(3):317-25. PubMed ID: 6706437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].
    Metzger JP; Montgermont P; N'Koua JL; Baubion N; Adams C; Meilhac B; Le Pailleur C; Vacheron A
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):377-80. PubMed ID: 4026163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
    Ourbak P; Lardoux H; Pornin M; Bouziri S; Allal J; Duong TC; Sellier P; Maurice M
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1089-96. PubMed ID: 3929738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholamines.
    Struthers AD; Reid JL
    Postgrad Med J; 1983; 59 Suppl 3():104-5. PubMed ID: 6647195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.